Shanxi Antai GroupLtd Temettü

Temettü kriter kontrolleri 0/6

Shanxi Antai GroupLtd şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Improved Revenues Required Before Shanxi Antai Group Co.,Ltd (SHSE:600408) Stock's 28% Jump Looks Justified

Oct 01

Lacklustre Performance Is Driving Shanxi Antai Group Co.,Ltd's (SHSE:600408) Low P/S

Jun 05

The Market Doesn't Like What It Sees From Shanxi Antai Group Co.,Ltd's (SHSE:600408) Revenues Yet

Feb 27

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 600408 şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: 600408 şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Shanxi Antai GroupLtd Piyasaya Karşı Temettü Getirisi

600408 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (600408)	n/a
Pazarın Alt %25'i (CN)	0.5%
Pazarın En İyi %25'i (CN)	2.1%
Sektör Ortalaması (Metals and Mining)	2.1%
Analist tahmini (600408) (3 yıla kadar)	n/a

Önemli Temettü: 600408 şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, 600408 şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: 600408 şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 600408 herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Shanxi Antai GroupLtd Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Third quarter 2024 earnings released: CN¥0.12 loss per share (vs CN¥0.16 loss in 3Q 2023)

Improved Revenues Required Before Shanxi Antai Group Co.,Ltd (SHSE:600408) Stock's 28% Jump Looks Justified

Shanxi Antai Group Co.,Ltd to Report Q3, 2024 Results on Oct 26, 2024

Shanxi Antai Group Co.,Ltd (SHSE:600408) signed a letter of intent to acquire an unknown minority stake in Shanxi Jiexiu Xinyugou Zuozegou Coal Industry Co., Ltd. from Yang Ruiping for CNY 500 million.

Shanxi Antai Group Co.,Ltd (SHSE:600408) signed a letter of intent to acquire an unknown minority stake in Shanxi Jiexiu Xinyugou Zuozegou Coal Industry Co., Ltd. from Yang Ruiping for CNY 500 million.

Second quarter 2024 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 2Q 2023)

Shanxi Antai Group Co.,Ltd to Report First Half, 2024 Results on Aug 30, 2024

Lacklustre Performance Is Driving Shanxi Antai Group Co.,Ltd's (SHSE:600408) Low P/S

Shanxi Antai Group Co.,Ltd, Annual General Meeting, May 21, 2024

First quarter 2024 earnings released: CN¥0.12 loss per share (vs CN¥0.12 loss in 1Q 2023)

Shanxi Antai Group Co.,Ltd, Annual General Meeting, May 21, 2024

Full year 2023 earnings released: CN¥0.67 loss per share (vs CN¥0.29 loss in FY 2022)

Shanxi Antai Group Co.,Ltd to Report Q1, 2024 Results on Apr 27, 2024

The Market Doesn't Like What It Sees From Shanxi Antai Group Co.,Ltd's (SHSE:600408) Revenues Yet

New minor risk - Share price stability

Shanxi Antai Group Co.,Ltd to Report Fiscal Year 2023 Results on Apr 25, 2024

New major risk - Share price stability

Third quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.15 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.15 loss per share (vs CN¥0.063 profit in 2Q 2022)

Shanxi Antai Group Co.,Ltd to Report First Half, 2023 Results on Aug 26, 2023

Full year 2022 earnings released: CN¥0.29 loss per share (vs CN¥0.28 profit in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.01 profit in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.063 (vs CN¥0.19 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.05 (vs CN¥0.25 in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.28 (vs CN¥0.33 in FY 2020)

Now 22% undervalued

Now 20% undervalued after recent price drop

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.01 (vs CN¥0.06 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.031 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.33 (vs CN¥0.45 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥3.10

Investor sentiment improved over the past week

New 90-day high: CN¥2.99

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥2.29

Shanxi Antai Group Co., Ltd. (SHSE:600408) agreed to acquire additional 18% stake in Shanxi Xintai Fu'an New Materials Co., Ltd. from Shanxi Xintai Iron & Steel Co., Ltd. for approximately CNY 220 million.

Shanxi Antai Plans to Buy 18% Stake in New Materials Firm

New 90-day high: CN¥2.02

Third quarter earnings released

Shanxi Antai Group Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

New 90-day low: CN¥1.74

First half earnings released

New 90-day high - CN¥1.98

Shanxi Antai Group Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin